NYSE:ZTS - New York Stock Exchange, Inc. - US98978V1035 - Common Stock - Currency: USD
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
Each stock has a return on invested capital between 17% and 27%, showing a strong ability to reinvest in their businesses profitably. Here's why now is the time to consider buying three of my favorite S&P 500 dividend stocks on the dip, while their shares are currently down between 19% and 26% from their highs. Zoetis (NYSE: ZTS) is the top dog in the animal healthcare industry and has outpaced the S&P 500 since its initial public offering (IPO) in 2013.
Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Stifel analyst Jonathan Block downgraded Zoetis Inc. (NYSE:ZTS)’s stock to “Hold” from “Buy,” reducing the price objective to $160 from $165. The firm warned that revenue growth might fall short of Wall Street expectations over the […]
Mentions: MRK
ADRNY vs. CLX: Which Stock Is the Better Value Option?
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
GOOS vs. IDEXY: Which Stock Is the Better Value Option?
HMY vs. FNV: Which Stock Is the Better Value Option?
Stifel Financial downgraded Zoetis stock on Wednesday, causing the animal health company’s shares to fall 4% on the news. The analyst downgrade created a possible long straddle for options investors. The question is whether it’s the best strategy.
Mentions: IDXX
U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again called on Fed Chair Jerome Powell to cut interest rates.
Brookfield Infrastructure and Brookfield Renewable plan to increase their dividends by 5% to 9% each year. Realty Income has raised its dividend 130 times since coming public 30 years ago. Enterprise Products Partners has increased its distribution for 26 straight years.
Steady growth and dividend increases over decades can make investors remarkably wealthy.
It has a plan to turn things around, which includes shrinking its volumes to grow its free cash flow. Tariffs, slowing economic growth, and low margins on volumes from its largest customer, Amazon (NASDAQ: AMZN), have impacted the leading global logistics company's revenue and cash flow, which has, in turn, weighed on its share price. For an income-focused investor like myself, UPS' big-time dividend yield is very appealing.
- Pyth Network is the first to publish live ETF prices on blockchains, covering $8 trillion in assets. - Real-time feeds cover more than 100 ETFs from BlackRock, Vanguard and State Street, sourced from institutional venues. - The technology democratizes market data traditionally controlled by expensive legacy providers.
UnitedHealth Group continued its historic drop in May, losing 26.6% during the month. The health insurer is facing new allegations of fraud and misconduct. Shares of UnitedHealth Group (NYSE: UNH) fell in May, finishing the month down 26.6%.
Quantum computing could change the world over the coming decades. It's not too early to think about how to profit from this generational technological leap.
Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: IRWD
ZTS jumps 13% in a month as strong new product sales, strategic deals, and rising earnings estimates boost investor confidence.
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: RXRX
We recently published a list of These 10 Stocks Are On Fire Right Now. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Wednesday’s best-performing stocks. Recursion Pharmaceuticals increased by 11.85 percent on Wednesday to end at $4.91 apiece as investors continued to gobble up […]